AKTS · Aktis Oncology, Inc.
$24.81
+0.18 (+0.73%)
At close · Jul 22
Market Cap
$1.37B
Shares
55.28M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
62/100
Short interest 6.0% of shares — P78
Days to cover 5.0 — P80
Price vs VWAP -1.2% — P49
Short-volume trend -9.4% — P20
Short interest change +13.5% — P71
Worst FTD 0.02% of shares — P52
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 3,306,972 | 2,913,924 | +393,048 | 4.99 |
| 2026-06-15 | 2,913,924 | 2,666,881 | +247,043 | 11.57 |
| 2026-05-29 | 2,666,881 | 2,527,598 | +139,283 | 18.39 |
| 2026-05-15 | 2,527,598 | 2,570,690 | -43,092 | 16.71 |
| 2026-04-30 | 2,570,690 | 2,341,899 | +228,791 | 10.04 |
| 2026-04-15 | 2,341,899 | 2,320,091 | +21,808 | 8.36 |
| 2026-03-31 | 2,320,091 | 1,165,368 | +1,154,723 | 3.01 |
| 2026-03-13 | 1,165,368 | 1,000,396 | +164,972 | 5.72 |
| 2026-02-27 | 1,000,396 | 919,340 | +81,056 | 5.96 |
| 2026-02-13 | 919,340 | 195,957 | +723,383 | 3.52 |
| 2026-01-30 | 195,957 | 46,658 | +149,299 | 1.00 |
| 2026-01-15 | 46,658 | 0 | +46,658 | 1.00 |
Showing 1–12 of 12 settlements
Key facts
CIK
2035832
CUSIP
01021M104
13F (30d)
10 filings
10 filers
Visit website
Investor relations